Literature DB >> 8313486

Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.

.   

Abstract

This Memorandum reviews the results of research undertaken in animals and human subjects on once-a-month injectable contraceptives containing a progestogen and an estrogen, in particular the products Cyclofem and Mesigyna. Results from clinical trials, including effectiveness and side-effects, are evaluated and issues arising from health service research are discussed. The Memorandum concludes with a statement regarding the use of Cyclofem and Mesigyna as options for potential contraceptive users.

Entities:  

Keywords:  Animals, Laboratory; Clinical Research; Clinical Trials; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Methods; Diseases; Family Planning; Health; Injectables; Literature Review; Menstruation Disorders; Public Health; Reversibility; Safety; World

Mesh：

Substances：

Year:  1993        PMID： 8313486      PMCID： PMC2393537     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  27 in total

1.  OVULATION INHIBITION WITH A LONG-ACTING PARENTERAL PROGESTOGEN-ESTROGEN COMBINATION.

Authors:  M L TAYMOR; S PLANCK; C YAHIA
Journal:  Fertil Steril       Date:  1964 Nov-Dec       Impact factor: 7.329

2.  Conception control by long-acting progestogens: preliminary report.

Authors:  I SIEGEL
Journal:  Obstet Gynecol       Date:  1963-06       Impact factor: 7.661

3.  FDA requirements for nonclinical testing of contraceptive steroids.

Authors:  A Jordan
Journal:  Contraception       Date:  1992-12       Impact factor: 3.375

4.  The monthly injectable contraceptive: a two-year clinical trial.

Authors:  S Koetsawang; S Srisupandit; O Kiriwat; A Koetsawang
Journal:  Int J Gynaecol Obstet       Date:  1978       Impact factor: 3.561

5.  Ovulation inhibition with a long-acting injectable contraceptive. IV. Return of reproductive function after discontinuation.

Authors:  M A Yussman; M L Taymor
Journal:  Am J Obstet Gynecol       Date:  1970-11-15       Impact factor: 8.661

6.  Control of fertility by monthly injection of estrogen-progestogen.

Authors:  G M Herzog; S D Soule
Journal:  Obstet Gynecol       Date:  1968-07       Impact factor: 7.661

7.  A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive.

Authors:  E von Kesserü; S Aydinlik; J J Etchepareborda; J Kaufmann
Journal:  Contraception       Date:  1991-12       Impact factor: 3.375

8.  A comparison of the pharmacokinetic properties of three estradiol esters.

Authors:  M A Oriowo; B M Landgren; B Stenström; E Diczfalusy
Journal:  Contraception       Date:  1980-04       Impact factor: 3.375

9.  A preliminary pharmacological trial of the monthly injectable contraceptive cycloprovera.

Authors:  K Fotherby; G Benagiano; H K Toppozada; A Abdel-Rahman; F Navaroli; B Arce; R Ramos-Cordero; C Gual; B M Landgren; E Johannisson
Journal:  Contraception       Date:  1982-03       Impact factor: 3.375

10.  Transfer of contraceptive steroids in milk of women using long-acting gestagens.

Authors:  S Koetsawang; P Nukulkarn; K Fotherby; K Shrimanker; M Mangalam; K Towobola
Journal:  Contraception       Date:  1982-04       Impact factor: 3.375
View more
  3 in total

Review 1.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

Authors:  D Heather Watts; Jeong-Gun Park; Susan E Cohn; Song Yu; Jane Hitti; Alice Stek; Pamela A Clax; Laila Muderspach; Juan J L Lertora
Journal:  Contraception       Date:  2007-12-21       Impact factor: 3.375

3.  Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant.

Authors:  Wanren Zheng; Yibo Tang; Chunfen Wang; Xiaocen Niu; Zhida Qian; Lili Huang
Journal:  BMC Womens Health       Date:  2021-12-29       Impact factor: 2.809
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.